Mizumura T, Nithipatikom K, Gross G J
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee 53226, USA.
Cardiovasc Res. 1995 Apr;29(4):482-9.
The major aim of this study was to determine if nicorandil, a potassium channel opener nitrate, produces a reduction in myocardial infarct size at a non-hypotensive dose in dogs and to determine if this effect is the result of an increase in adenosine release or reduction in neutrophil infiltration into the ischaemic area. Glyceryl trinitrate was used for purposes of comparison.
Barbitone anaesthetised dogs were subjected to 60 min of left anterior descending coronary artery occlusion followed by 3 h of reperfusion. Nicorandil (100 microgram.kg-1 bolus followed by a 10 microgram.kg-1.min-1 infusion; NC/pre group), glyceryl trinitrate (10 microgram.kg-1 bolus followed by a 1 microgram.kg-1.min-1 infusion; GTN/pre group), or an equivalent volume of saline (control group) were given intravenously 15 min before occlusion and continued to the time of reperfusion. In two other groups, nicorandil (NC/post group) or glyceryl trinitrate (GTN/post group) were given 10 min before reperfusion and continued until the end of the experiment. To measure the release of adenosine from the ischaemic region, coronary venous blood samples were collected before occlusion, during occlusion, and at various times following reperfusion. Myocardial infarct size was determined by triphenyltetrazolium chloride and transmural myocardial blood flow by radioactive microspheres. Transmural myeloperoxidase activity, an index of neutrophil infiltration, was measured in biopsies obtained from the area at risk.
Pretreatment with nicorandil and glyceryl trinitrate caused a marked reduction in myocardial infarct size expressed as percent of the area at risk [NC/pre group, 7.8(SEM 1.6)%; GTN/pre group, 11.9(2.3)%; control group, 31.0(5.6)%]. When nicorandil and glyceryl trinitrate were given before reperfusion, both drugs still produced a significant reduction in infarct size [NC/post group, 13.8(2.0)%; GTN/post group, 18.9(4.3)%]. Coronary venous adenosine concentrations during reperfusion were significantly lower in both nicorandil and glyceryl trinitrate pretreated groups, but not in the post-treated groups. Transmural myeloperoxidase activity was significantly lower in both nicorandil treated groups.
Pretreatment with a non-hypotensive dose of nicorandil or glyceryl trinitrate markedly reduces myocardial infarct size and adenosine release from the ischaemic-reperfused area. These agents were also effective, but to a lesser degree, when given just before reperfusion. The cardioprotective actions of nicorandil appear to be related not only to its potassium channel opening activity but also in part to its nitrate activity.
本研究的主要目的是确定钾通道开放剂硝酸酯类药物尼可地尔在犬非低血压剂量下是否能减小心肌梗死面积,并确定该效应是否是由于腺苷释放增加或中性粒细胞向缺血区域浸润减少所致。使用硝酸甘油作为对照。
用巴比妥麻醉犬,使其左前降支冠状动脉闭塞60分钟,随后再灌注3小时。在闭塞前15分钟静脉注射尼可地尔(100微克·千克⁻¹推注,随后以10微克·千克⁻¹·分钟⁻¹输注;NC/预处理组)、硝酸甘油(10微克·千克⁻¹推注,随后以1微克·千克⁻¹·分钟⁻¹输注;GTN/预处理组)或等量生理盐水(对照组),并持续至再灌注时。在另外两组中,在再灌注前10分钟给予尼可地尔(NC/后处理组)或硝酸甘油(GTN/后处理组),并持续至实验结束。为了测量缺血区域腺苷的释放,在闭塞前、闭塞期间和再灌注后的不同时间采集冠状静脉血样。用氯化三苯基四氮唑测定心肌梗死面积,用放射性微球测定透壁心肌血流量。在从危险区域获取的活检组织中测量透壁髓过氧化物酶活性,作为中性粒细胞浸润的指标。
尼可地尔和硝酸甘油预处理使心肌梗死面积显著减小,以危险区域面积的百分比表示[NC/预处理组,7.8(标准误1.6)%;GTN/预处理组,11.9(2.3)%;对照组,31.0(5.6)%]。当在再灌注前给予尼可地尔和硝酸甘油时,两种药物仍使梗死面积显著减小[NC/后处理组,13.8(2.0)%;GTN/后处理组,18.9(4.3)%]。尼可地尔和硝酸甘油预处理组再灌注期间冠状静脉腺苷浓度均显著降低,但后处理组未降低。尼可地尔处理的两组透壁髓过氧化物酶活性均显著降低。
非低血压剂量的尼可地尔或硝酸甘油预处理可显著减小心肌梗死面积,并减少缺血再灌注区域的腺苷释放。在再灌注前给药时,这些药物也有效,但程度较小。尼可地尔的心脏保护作用似乎不仅与其钾通道开放活性有关,还部分与其硝酸酯活性有关。